‌

US Patent 10688104 Combination therapy with Notch and PD-1 or PD-L1 inhibitors

Patent 10688104 was granted and assigned to Eli Lilly and Company on June, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106881040

Date of Patent

June 23, 2020

Patent Application Number

163013600

Date Filed

May 16, 2017

Patent Citations Received

‌

US Patent 11564929 Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer

‌

US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer

‌

US Patent 11376259 Targeted treatment of mature T-cell lymphoma

Patent Primary Examiner

‌

Karl J Puttlitz

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10688104 Combination therapy with Notch and PD-1 or PD-L1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API